Leaders of the Antibody sector: An interview with Associate Director with Mark Chiu, Janssen Research & Development LLC

Leaders of the Antibody sector: An interview with Associate Director Mark Chiu, Janssen Research and Development LLC

Following on from our recent interview with Georg Fey, SpectraMab’s CSO, we’ve also had the pleasure of catching up with Mark Chiu, Associate Director of Janssen Research & Development LLC. Total Biopharma chats with Chiu about the latest challenges and upcoming developments within the Antibody sphere. And while Chiu’s answers are specific and straight-to-the-point, if you want to hear more …